Nucleophosmin 1 | Clinical Trial Radar

Trial Radar AI Trial Candidate or Patient Patient Caregiver Healthcare Pro Biotech Pro Biotech Investor Researcher Other
	Let's discuss and explore clinical trials with Syndax Pharmaceuticals as a lead sponsor or collaborator. I can help you find nearby clinical trials and understand health conditions and treatments.

Let's discuss and explore clinical trials with Syndax Pharmaceuticals as a lead sponsor or collaborator.

I can help you find nearby clinical trials and understand health conditions and treatments.

Study Title	Status
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation (REVEAL-ND NPM1) NCT07211958	Recruiting
A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias NCT06226571	Recruiting
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation (AUGMENT-101) NCT04065399	Recruiting